The Link Between Levels of Epstein-Barr Virus VCA-IgA Antibodies and Cancer Risk – IARC
IARC – International Agency for Research on Cancer / World Health Organization shared on LinkedIn:
“New study from IARC and partners explores the link between levels of Epstein-Barr virus (EBV) capsid antigen (VCA-IgA) antibodies, which are produced in response to EBV infection, and cancer risk.
Findings reveal significant associations between the presence of antibodies and increased risk of multiple cancers.”
Title: Epstein-Barr virus antibody and cancer risk in two prospective cohorts in Southern China
Journal: Nature Communications
Authors: Ming-Fang Ji, Yong-Qiao He, Min-Zhong Tang, Wen-Qiong Xue, Xia Yu, Hua Diao, Da-Wei Yang, Zhi-Ming Mai, Io Hong Cheong, Zhi-Yang Zhao, Biao-Hua Wu, Fu-Gui Li, Ji-Yun Zhan, Chang-Ling Huang, Hao-Lin Ma, Jun Li, Yan-Cheng Li, Tong-Min Wang, Ying Liao, Xue-Yin Chen, Zhi-Heng Liang, Shi-Feng Lian, Yun Du, Xue-Jun Liang, Zisis Kozlakidis, Jun Ma, Wei-Hua Jia
More posts featuring IARC on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023